Industry Education

The Society of Critical Care Medicine’s (SCCM) 46th Critical Care Congress will be packed with essential clinical information to keep you informed on the latest groundbreaking research and developments in critical care. Each year, industry partners invest significant resources in research and development, placing them at the cutting edge of clinical practice.


 Promotional Symposia


Industry partners invest significant resources in research and development, and stand at the cutting edge of clinical practice. These programs, developed and sponsored by industry partners, will provide insight into the latest controversial developments affecting ICUs. Promotional symposia take place in a relaxed setting off site, and attendance is free.

Sunday, January 22, 2017

5:00 p.m. — 6:30 p.m.
Optiflow™ Nasal High Flow: What Really Matters?
Organized by Fisher & Paykel Healthcare
Location: Hilton Hawaiian Village, Mid-Pacific Tower, Ballroom Coral 3
This presentation will be delivered by world leading experts in the field and will review the current evidence for this therapy and evaluate both the emerging and clinically significant applications for it.

6:00 p.m — 7:30 p.m
Reviewing the New, 4-Oil Lipid Emulsion through Patient Cases
Organized by Fresenius Kabi
Location: Hilton Hawaiian Village, Mid-Pacific Tower, Ballroom Coral 4
During this program, the experts will discuss the importance of lipids as part of parenteral nutrition (PN) and identify features of Smoflipid®, a new 4-oil lipid emulsion option, for adult patients. Additionally, the experts will explore the use of Smoflipid through patient case studies and address questions from the audience.

6:00 p.m — 7:30 p.m
Diagnosis and Management of Super-Refractory Status Epilepticus
Organized by Sage Therapeutics
Location: Hilton Hawaiian Village, Mid-Pacific Tower, Ballroom Coral 1 & 2
Super-refractory status epilepticus (SRSE) is a life-threatening form of status epilepticus that continues or recurs despite multiple therapeutic interventions, including general anesthetics. Rapid treatment and termination of the crisis is crucial because uncontrolled seizures can take an enormous toll, resulting in neuronal injury, loss of cognitive function and death.

6:00 p.m — 7:30 p.m
Resistant Gram-Negative Organisms in the ICU: Considerations for the Prevention, Management, and Resolution of Outbreaks
Organized by The Medicines Company
Location: Hilton Hawaiian Village, Mid-Pacific Tower, Ballroom Coral 5
Learn about the options to identify, preempt, and combat resistant gram-negative pathogens in the ICU. Understand the significance on morbidity, mortality, costs and length of stay. Stewardship and early identification can help prevent and manage these infections. Considerations of current and future antimicrobial agents as a management tactic will be discussed.

Monday, January 23, 2017

6:00 p.m. – 7:30 p.m.
Navigating the Perioperative Nutrition Landscape
Organized by Abbott Nutrition
Location: Hilton Hawaiian Village, Mid-Pacific Tower, Ballroom Coral 1 & 2
This symposium will explore the impact of malnutrition on surgical outcome and the clinical and immune effects of early postoperative enteral nutrition. The mechanism for surgery-associated insulin resistance and the evidence for carbohydrate loading will be reviewed along with the current evidence and surgical nutrition guidelines, including the role of immunonutrition.

6:00 p.m. – 7:30 p.m.
Catecholamine-Resistant Hypotension: The Magic 8 Ball Versus Current Practice
Organized by La Jolla Pharmaceutical Company
Location: Hilton Hawaiian Village, Mid-Pacific Tower, Ballroom Coral 4
Intensivists, faced with conflicting clinical evidence, frequently resort to unproven and other “voodoo” treatments in the management of shock. Catacholamine-resistant hypotension (CRH) is a life-threatening syndrome that occurs when patients are no longer responsive to appropriate doses of catecholamine therapies. This symposium will explore epidemiology, morbidity and mortality associated with CRH, current treatment modalities, current evidence, controversies and new approaches to management of CRH.

6:00 p.m. – 7:30 p.m.
The Role of Procalcitonin in Bacterial Infection and Patient Management
Organized by Thermo Fisher Scientific
Location: Hilton Hawaiian Village, Mid-Pacific Tower, Ballroom Coral 5
This symposium will describe the role of procalcitonin in aiding the clinical risk assessment and management of patients with severe bacterial infections at risk for developing sepsis in the emergency department (ED) and the intensive care unit (ICU), from the perspective of an ED physician, an ICU physician and a pharmacist.


 In-Booth Education


Visit the Exhibit Hall to gain new ideas and a heightened level of awareness on clinical topics and new technologies through in-booth learning opportunities. In-booth education will take place during regular Exhibit Hall hours.

Booth #627
410 Medical
In-booth LifeFlow® Rapid Infuser demonstrations led by Dr. Mark Piehl, Chief Medical Officer, and Christine O’Neill, Lead Clinical Specialist. LifeFlow is 410 Medical’s new product for enhancing the speed and efficiency of fluid resuscitation and improving care for patients with life-threatening illnesses.

Booth #1133
American Thoracic Society
Sunday, January 22, 2017, 10:00 a.m. – 10:30 a.m.
The Critical Care (CC) Assembly, the largest ATS assembly with over 6,000 members, helps members improve the care of the critically ill through education, research, and professional development. Meet Carolyn Calfee, MD, CC Chair, to learn more about its services, including clinical resources, conference sessions, journal clubs, mentorship, and scholarships.

Booth #932
Baxter Healthcare Corporation
Phosphate, The Forgotten Electrolyte. In this session, Pamela Waters, RN, will review the importance of managing electrolyte imbalances as well as reviewing phosphate and its role as an electrolyte. Within the ICU there are many options available for management of phosphate in the critically ill patient undergoing CRRT. Sunday, January 22, 2017 at 9:00 a.m., 11:00 a.m. and 1:00 p.m., and Monday, January 23, and Tuesday, January 24, 2017 at 8:00 am, 10:00 am, and 12:00 pm.

Booth #606
CytoSorbents Corporation
Please visit CytoSorbents Corporation’s booth (#606) to learn how our advanced porous polymer bead-based blood purification technology can help control deadly inflammation in life-threatening conditions such as sepsis, trauma, lung injury, liver failure, pancreatitis, complications of surgery, toxin-mediated diseases, and many others. For more information, go to: and

Booth #916
EKOS Corporation, a BTG International Group Company
EKOS Therapy is a minimally invasive system for dissolving thrombus. The ultrasonic core generates a localized acoustic field that targets the entire thrombus. This greatly accelerates lytic dispersion by driving the drug deeper into the clot and unwinding the fibrin to expose plasminogen receptor sites. See us at booth #916 to learn more.

Booth #814
Exergen Corporation
Please visit our booth at any time and ask for our 4-second demonstration of the correct way to take a patient temperature with the Exergen temporal thermometer. Pick up an inservice CD and a list of over 50 studies documenting Exergen’s accuracy!

Booth #1102
Extracorporeal Life Support Organization (ELSO)
The Extracorporeal Life Support Organization (ELSO) will hold ongoing educational sessions for healthcare professionals on topics such as: Building an ECMO Program and Structuring an ECMO Education Program. Please visit our booth for in-depth discussions, as well as learning about resources to assist ECMO centers in achieving their program goals.

Booth #615
The JAMA Network
Learn how to access JAMA’s Caring for the Critically Ill Patient series and other content with the JAMA Network Reader. Stop by the JAMA Network booth to register for FREE access to critical care articles from JAMA and 11 specialty journals on your mobile device.

Booth #502
La Jolla Pharmaceuticals
Catecholamine-resistant hypotension (CRH) is an acute and lifethreatening syndrome. Learn more about its prevalence, impact and limitations of current treatments at the La Jolla Pharmaceutical booth. Visit Booth 502 to view educational materials, speak with company representatives and take a survey to help raise $5,000 for the Sepsis Alliance.

Booth #1027
Lantheus Medical Imaging, Inc.

Lantheus Medical Imaging offers the #1 prescribed ultrasound enhancing agent in the U.S. for suboptimal echocardiograms. Clinical case studies will illustrate how ultrasound enhancing agents may improve echo quality and diagnostic outcomes in critical care patients. Participants may also test their ability to assess an enhanced echocardiogram through an interactive exhibit.

Booth #1015
Nestlé Health Science
Learn how Nestlé Health Science can help you successfully implement the Critical Care Nutrition Guidelines in your practice. Visit our Booth #1015 to view videos featuring two of the guideline athors and pick up documents created for the guidelines.

Booth #1022
Philips unites advanced technologies in Tele-ICU and Ultrasound this year to showcase the future of critical care. On-booth clinicians will present the made-for-population-health CensusMosaic graphical census embedded in the eICU Program. Additionally, Philips Ultrasound will spotlight the newest transducers and enhancements on Sparq and Lumify, the revolutionary app-based ultra-mobile ultrasound.

Booth #511
Restorative Therapies, Inc.
In-booth education by Restorative Therapies Critical Care specialists includes: Clinical applications of RT300 supine cycling in adult and pediatric Early Mobility programs. Research on supine cycling including multi-center trials utilizing RT300 supine cycle. Enhancing outcomes through supine cycling with minimal demand on ICU nursing and therapy staff.

Booth #516
Smiths Medical
Smiths Medical (booth #516) will feature our expansive airway management products. Explore hands-on demonstrations of our surgical and percutaneous tracheostomy tubes available in PVC and flexible silicone options. In addition, our respiratory care solutions including closed suction catheters, passive humidification systems, filtration products, and much more.

Booth #1137
Join SonoSim at Booth 1137 and diagnose our in-booth critical care patient with SonoSim® LiveScan technology. Participants will be provided with a case history and asked to examine the patient with the SonoSim® Ultrasound Training Solution in the time allotted. Review your findings with the SonoSimulator®.

Booth #922
Trinity Health
Critical Care Information at the Right Place and Right Time. Critical care environments are at particularly high risk of problems related to information overload. We are conducting knowledge elicitation activities to better understand how critical care clinicians organize and prioritize patient information. This information will be used to enhance information design to support clinicians’ situation awareness.

Booth #816
Virtual Pediatric Systems, LLC
Visit the Virtual Pediatric Systems (“VPS”) booth to see a demonstration on how to analyze collaborative VPS data (from over 135 units) for quality improvement initiatives that are customizable for your unit. See firsthand how to utilize the VPS tools to facilitate granular drill-down for process improvement and site specific initiatives.


 Exhibitor-Sponsored Industry Education Workshops


Attend exhibitor-sponsored industry education workshops during session breaks. Located in the Exhibit Hall, these workshops will provide additional learning opportunities and insight on latebreaking technology or clinical techniques.

Sunday, January 22, 2017

11:30 a.m. – 12:30 p.m.
Patient Management and Optimizing Care with the Application of a Bacterial Infection-Specific
Diagnostic Biomarker (Theater 1)
Sponsored by bioMerieux
Presenters: Robert A. Balk, MD; Devendra N. Amin, MD
Explore the application of procalcitonin levels to aid in monitoring treatment response in bacterial infections. Case studies will illustrate how monitoring procalcitonin levels over time can aid in adjusting medical care in the ICU to optimize decisions regarding patient care and discharge to the ward.

11:30 a.m. – 12:30 p.m.
Patient Selection in PE Intervention (Theater 2)

Sponsored by EKOS Corporation
Presenter: Victor F. Tapson, MD, FCCP, FRCP
Which pulmonary embolism patients need intervention and how do you appropriately identify and manage their treatment? Come hear a lively case-based discussion on some innovative ways of evaluating and treating intermediate-risk patients, in light of the 2016 CHEST Guidelines on Antithrombotic Therapy for VTE Disease. Also included is an update on a promising clinical trial on low-dose, catheter-directed thrombolysis.

Monday, January 23, 2017

9:30 a.m. – 10:30 a.m.
Vascular Access Decision-Making in the ICU: Championing Appropriate Device Selection (Theater 1)
Sponsored by Bard Access
Presenter: Gregory J. Schears, MD
Dr. Gregory Schears will present a patient-centered approach for vascular access selection in the ICU. Successful and safe central vascular access in the ICU cannot be simplified to a blanket recommendation; it is a function of choosing the right device and approach for each patient while adhering to modern insertion and maintenance practices for each device.

9:30 a.m. – 10:30 a.m.
Mitigating Risks of Transfusion-Transmitted Infection and TA-GVHD with Pathogen-Reduced Blood Components (Theater 2)

Sponsored by Cerus Corporation
Presenter: Jeff Huxford, MMSc
Bacterial contamination and emerging pathogens present the leading transfusion-related safety risks today. Pathogen reduction is a proactive approach to mitigating such risks via inactivation of viruses, bacteria, parasites and leukocytes in plasma and platelet components. Data will be presented to describe and evaluate the efficacy and safety of pathogen-reduced components.

Tuesday, January 24, 2017

9:30 a.m. – 10:30 a.m.
The Benefits of Rapid Diagnostic Testing in the Management of Infection (Theater 1)
Sponsored by BioFire
Presenter: Robert A. Balk, MD
Learn about the clinical and economic benefits of syndromic infectious disease testing and the FilmArray® Meningitis/Encephalitis and Blood Culture Identification Panels.

9:30 a.m. – 10:30 a.m.
The Great Temperature Management Debate (Theater 2)

Sponsored by ZOLL Medical
Presenters: Presenters: Nicolas Deye, MD; Michael C. Kurz, MD, MS-HES, FACEP, FAHA
Targeted Temperature Management (TTM), which encompasses fever control and therapeutic hypothermia (TH), has become an increasingly important therapy in critically ill patients. Comparative data on cooling methods and technologies have been scarce, but recently more information has become available. The ICEREA study, a newly published multicenter, prospective, randomized controlled trial (RCT), is the largest RCT to directly compare surface cooling to intravascular cooling. The study shows a clear trend toward better neurological outcomes with intravascular cooling, as well as a significant reduction in time required for TTM-related nursing intervention and cooling initiation.